RBM10

{{Short description|Protein-coding gene in the species Homo sapiens}}

RNA-binding motif 10 is a protein that is encoded by the RBM10 gene. This gene maps on the X chromosome at Xp11.23 in humans. RBM10 is a regulator of alternative splicing. Alternative splicing is a process associated with gene expression to produce multiple protein isoforms from a single gene, thereby creating functional diversity and cellular complexity. RBM10 influences the expression of many genes, participating in various cellular processes and pathways such as cell proliferation and apoptosis. Its mutations are associated with various human diseases such as TARP syndrome,{{cite journal |last1=Gorlin |first1=RJ |last2=Cervenka |first2=J |last3=Anderson |first3=RC |last4=Sauk |first4=JJ |last5=Bevis |first5=WD |title=Robin's syndrome. A probably X-linked recessive subvariety exhibiting persistence of left superior vena cava and atrial septal defect. |journal=American Journal of Diseases of Children |date=February 1970 |volume=119 |issue=2 |pages=176–8 |doi=10.1001/archpedi.1970.02100050178020 |pmid=5410571}} an X-linked congenital disorder in males resulting in pre‐ or postnatal lethality, and various cancers in adults.

Gene and protein

The RBM10 gene spans ~41.6 kb and contains 24 exons. This gene is subjected to X-inactivation, in which one of the two RBM10 genes in female cells is transcriptionally silenced by heterochromatin formation.

RBM proteins constitute a large family of RNA-binding proteins (RBPs). There are 52 RBM proteins (HGNC: HUGO Gene Nomenclature Committee), each containing one to several RNA-binding domains called RNA recognition motifs (RRMs). RBM10 contains two RRMs (RRM1 and RRM2) and other domains such as two zinc fingers (ZnFs), an octamer repeat (OCRE), three nuclear localization signals (NLSs), and a glycine-rich domain (G-patch). The amino acid (aa) sequence of RBM10 is conserved among mammals. Human RBM10 isoform 1 shares 96% and 97% sequence homology with those of mice and rats, respectively, indicating that the molecular functions of RBM10 are essentially the same in humans and rodents.

RBM10 has multiple isoforms, generated via alternative splicing events of the RBM10 primary transcript. The main isoforms, 1–4, may contain an exon 4 sequence (77 residues) and/or a Val residue corresponding to the last codon of exon 10. Isoform 1 (930 residues) contains both the exon 4 sequence and V354, whereas isoform 4 (929 residues) does not contain this valine residue. Similarly, the exon 4–minus isoform 3 (853 residues) contains V277, whereas isoform 2 (852 residues) does not. Isoform 5 (995 residues) has a longer 65-aa N-terminus, compared with that of isoform 1. In addition, automated computational analysis using the Gnomon gene prediction tool (NCBI gene) has shown that there may be more than 10 different RBM isoforms.

Function

RBM10 is ubiquitously expressed in almost every type of cell, both growing as well as quiescent (UniProtKB-P98175 [human] and Q99KG3 [mouse]; The Human Protein Atlas). In general, it is more strongly expressed in actively transcribing cells.

In the alternative splicing regulation, RBM10 promotes the exclusion of an exon, called a cassette or alternative exon, from target pre-mRNAs, and less frequently, other alternative splicing events such as alternative 5ʹ-splice site selection. In the exon skipping process, RBM10 binds close to the 3ʹ- and 5ʹ-splice sites of cassette exons and interferes with the recognition and/or the pairing of the splice sites, thereby enhancing the pairing of the splice sites distal to the cassette exons, which ultimately leads to the exclusion of the exons together with the flanking upstream and downstream introns.

The diversity of target RNAs bound by RBM10 in cells suggests that it is involved in various metabolic processes such as oxidative phosphorylation; pathways linked to cell proliferation, apoptosis, cell adhesion, and actin/cytoskeleton reorganization; and various diseases such as cancers and neurodegenerative diseases. These data, together with the ubiquitous expression of RBM10, indicate that it is a fundamental cellular component participating in various cellular processes.

In addition to alternative splicing regulation, RBM10 participates in other reactions. Some examples are polyadenylation of cardiac pre-mRNAs of anti-hypertrophy regulators, wherein it acts as a co-regulator of STAR-poly(A) polymerase, stabilization of angiotensin II receptor mRNA by binding to its 3ʹ-UTR, let-7g miRNA biogenesis through interaction with its precursor, p53 stabilization by binding to its negative regulator, MDM2, cell cycle arrest, and anti-viral reactions.

RBM10 localizes to the nucleoplasm, where transcription and splicing occur, as well as in membrane-less nuclear compartments called S1-1 nuclear bodies (S1-1 NBs). The numbers (ca. 10–40 per nucleus) and sizes (ca. 0.5 μm) of S1-1 NBs vary with the cell type and cellular conditions. When RNA polymerase II transcription decreases, RBM10 in the nucleoplasm is sequestered in S1-1 NBs, which become larger and spherical; when transcription is restored, RBM10 and the S1-1 NBs return to their initial states. S1-1 NBs often overlap with nuclear speckles (also known as splicing speckles or interchromatin granule clusters), seemingly indicating a close functional relationship between these nuclear domains, i.e., alternative splicing regulation and splicing reaction.

Regulation

In females, most genes on one of the two X chromosomes are transcriptionally silenced by heterochromatin formation, and RBM10 is subjected to this X-inactivation. In addition, there are mechanisms to control elevated cellular levels of RBM10. RBM10 auto-regulates its overexpressed pre-mRNA by alternative splicing to exclude exon 6 or 12, which generates a premature stop codon in the transcripts, leading to their degradation through nonsense-mediated mRNA decay (NMD). When RNA polymerase II transcription decreases, RBM10 is sequestered in S1-1 NBs until transcription is restored. In addition, RBM10 undergoes post-translational modifications: phosphorylation at many sites in response to various stimuli and changes in cellular conditions (UniProtKB-P98175; PhosphoSitePlus RBM10), as well as ubiquitylation, acetylation, and methylation. However, the molecular and biological significance of these various post-translational modifications of RBM10 is not well understood.

Clinical significance

Mutations in RBM10 are associated with various human diseases. The phenotypes caused by RBM10 mutations differ by the stages of development and affected tissues. Typical examples are TARP syndrome, an X-linked pleiotropic developmental malformation in neonates, and various cancers such as lung adenocarcinoma (LUAD) and bladder carcinoma (BLCA) in adults. These diseases are more common in males than in females. One reason for this is the difference in the copy number of the RBM10 gene in a cell (one in male cells and two in female cells). Mutations in RBM10 occur throughout the molecule, and many of them are null mutations. TARP syndrome is generally pre- or postnatally lethal. However, patients aged 11, 14, and 28 years have been reported to escape these null mutations. RBM10 mutations have also been identified in other cancers such as renal carcinomas, pancreatic cancers, colorectal cancers, thyroid cancers, breast cancers, bile duct cancers, prostate cancer, and brain tumor meningiomas and astroblastomas.

NUMB is the most studied downstream effector of RBM10. RBM10 promotes the skipping of exon 9 of the NUMB transcript, producing a NUMB isoform that causes ubiquitination followed by proteasomal degradation of the Notch receptor, and thereby inhibits the Notch signaling cell-proliferation pathway. In various cancers, RBM10 mutations that inactivate or reduce its alternative splicing regulatory activity enhance the production of the exon 9–including NUMB isoform, which promotes cancer cell proliferation through the Notch pathway.

RBM10 suppresses cell proliferation and promotes apoptosis. Hence, it is generally regarded as a tumor suppressor. However, in certain cases, it may exert an opposite oncogenic function by acting as a tumor promoter or growth enhancer, presumably due to the cellular contexts composed of different constituents and active pathways. A typical example of this is patients with pancreatic ductal adenocarcinoma (PDAC) having RBM10 mutations, who exhibit a survival rate remarkably higher than the general 5-year PDAC survival rate of less than 7–8%.

Paralogs and splicing network

RBM5 and RBM6 are paralogs of RBM10. They were generated by gene duplications during genome evolution. They generally function as tumor suppressors, and their mutations are often identified in lung cancers. RBM5, RBM6, and RBM10 regulate alternative splicing and generally act on different RNAs; however, in certain cases, they act on the same subset of RNAs, likely producing synergistic or antagonistic effects. There is a cross-regulation between RBM5 and RBM10; RBM10 lowers RBM5 transcript levels by alternative splicing–coupled NMD. Furthermore, RBM10 perturbation (knockdown or overexpression) brings about splicing alterations in multiple splicing regulators, including RBM5, and also significantly influences the expression of other splicing regulators, including RBM10 itself. In addition, RBM10 primary transcripts are subjected to alternative splicing at several exons by unidentified splicing regulators, leading to the generation of multiple RBM10 isoforms. These data suggest the existence of an alternative splicing network formed by RBM5, RBM6, and RBM10, as well as other splicing regulators. Studies on such networks are expected to promote our understanding of transcriptomic homeostasis regulated by splicing and the molecular and biological significance of RBM10 in cells.

RBM10 regulates hundreds of genes. Further studies on the various RBM10-mediated processes and pathways may help elucidate the pathogenesis and progression of diseases caused by RBM10 mutations and the mechanisms of the antithetical actions of RBM10 as a tumor suppressor, and in certain cases, a tumor promoter, and provide clues for better treatment of the diseases.

Notes

References

{{reflist|refs =

{{cite journal | vauthors = Wang Y, Gogol-Döring A, Hu H, Fröhler S, Ma Y, Jens M, Maaskola J, Murakawa Y, Quedenau C, Landthaler M, Kalscheuer V, Wieczorek D, Wang Y, Hu Y, Chen W | display-authors = 6 | title = Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation | journal = EMBO Molecular Medicine | volume = 5 | issue = 9 | pages = 1431–42 | date = September 2013 | pmid = 24000153 | doi = 10.1002/emmm.201302663 | pmc = 3799496 }}

{{cite journal | vauthors = Bechara EG, Sebestyén E, Bernardis I, Eyras E, Valcárcel J | title = RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation | journal = Molecular Cell | volume = 52 | issue = 5 | pages = 720–33 | date = December 2013 | pmid = 24332178 | doi = 10.1016/j.molcel.2013.11.010 | doi-access = free | hdl = 10230/25288 | hdl-access = free }}

{{cite journal | vauthors = Inoue A, Yamamoto N, Kimura M, Nishio K, Yamane H, Nakajima K | title = RBM10 regulates alternative splicing | journal = FEBS Letters | volume = 588 | issue = 6 | pages = 942–7 | date = March 2014 | pmid = 24530524 | doi = 10.1016/j.febslet.2014.01.052 | s2cid = 10303057 | doi-access = free }}

{{cite journal | vauthors = Inoue A, Tsugawa K, Tokunaga K, Takahashi KP, Uni S, Kimura M, Nishio K, Yamamoto N, Honda K, Watanabe T, Yamane H, Tani T | display-authors = 6 | title = S1-1 nuclear domains: characterization and dynamics as a function of transcriptional activity | journal = Biology of the Cell | volume = 100 | issue = 9 | pages = 523–35 | date = September 2008 | pmid = 18315527 | doi = 10.1042/BC20070142 | s2cid = 9893063 }}

{{cite journal | vauthors = Zheng S, Damoiseaux R, Chen L, Black DL | title = A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing | journal = Genome Research | volume = 23 | issue = 6 | pages = 998–1007 | date = June 2013 | pmid = 23636947 | doi = 10.1101/gr.147546.112 | pmc = 3668367 }}

{{cite journal | vauthors = Loiselle JJ, Roy JG, Sutherland LC | title = RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5 | journal = PLOS ONE | year = 2017 | volume = 12 | issue = 6 | pages = e0180258 | pmid = 28662214 | doi = 10.1371/journal.pone.0180258 | pmc = 5491171 | bibcode = 2017PLoSO..1280258L | doi-access = free }}

{{cite journal | vauthors = Mueller CF, Berger A, Zimmer S, Tiyerili V, Nickenig G | title = The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms | journal = Archives of Biochemistry and Biophysics | volume = 488 | issue = 1 | pages = 76–82 | date = August 2009 | pmid = 19508861 | doi = 10.1016/j.abb.2009.06.002 }}

{{cite journal | vauthors = Hernández J, Bechara E, Schlesinger D, Delgado J, Serrano L, Valcárcel J | title = Tumor suppressor properties of the splicing regulatory factor RBM10 | journal = RNA Biology | year = 2016 | volume = 13 | issue = 4 | pages = 466–72 | pmid = 26853560 | doi = 10.1080/15476286.2016.1144004 | pmc = 4841610 }}

{{cite journal | vauthors = Zhao J, Sun Y, Huang Y, Song F, Huang Z, Bao Y, Zuo J, Saffen D, Shao Z, Liu W, Wang Y | display-authors = 6 | title = Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing | journal = Scientific Reports | volume = 7 | pages = 40488 | date = January 2017 | pmid = 28091594 | doi = 10.1038/srep40488 | pmc = 5238425 | bibcode = 2017NatSR...740488Z }}

{{cite journal | vauthors = Han LP, Wang CP, Han SL | title = Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration | journal = Médecine/Sciences | volume = 34 Focus issue F1 | pages = 81–86 | date = October 2018 | pmid = 30403180 | doi = 10.1051/medsci/201834f114 | doi-access = free }}

{{cite journal | vauthors = Jin X, Di X, Wang R, Ma H, Tian C, Zhao M, Cong S, Liu J, Li R, Wang K | display-authors = 6 | title = RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway | journal = Journal of Cellular and Molecular Medicine | volume = 23 | issue = 6 | pages = 3897–3904 | date = June 2019 | pmid = 30955253 | doi = 10.1111/jcmm.14263 | pmc = 6533519 }}

{{cite journal | vauthors = Jung JH, Lee H, Cao B, Liao P, Zeng SX, Lu H | title = RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53 | journal = Oncogene | volume = 39 | issue = 5 | pages = 1031–1040 | date = January 2020 | pmid = 31591476 | doi = 10.1038/s41388-019-1034-9 | pmc = 6994357 }}

{{cite journal | vauthors = Sutherland LC, Rintala-Maki ND, White RD, Morin CD | title = RNA binding motif (RBM) proteins: a novel family of apoptosis modulators? | journal = Journal of Cellular Biochemistry | volume = 94 | issue = 1 | pages = 5–24 | date = January 2005 | pmid = 15514923 | doi = 10.1002/jcb.20204 | s2cid = 26344717 }}

{{cite journal | vauthors = Wang K, Bacon ML, Tessier JJ, Rintala-Maki ND, Tang V, Sutherland LC | title = RBM10 Modulates Apoptosis and Influences TNF-α Gene Expression | journal = Journal of Cell Death | year = 2012 | volume = 5 | pages = 1–19 | pmid = 26446321 | doi = 10.4137/JCD.S9073 | pmc = 4583097 }}

{{cite journal | vauthors = Rodor J, FitzPatrick DR, Eyras E, Cáceres JF | title = The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development | journal = RNA Biology | volume = 14 | issue = 1 | pages = 45–57 | date = January 2017 | pmid = 27763814 | doi = 10.1080/15476286.2016.1247148 | pmc = 5270529 }}

{{cite journal | vauthors = Sun X, Jia M, Sun W, Feng L, Gu C, Wu T | title = Functional role of RBM10 in lung adenocarcinoma proliferation | journal = International Journal of Oncology | volume = 54 | issue = 2 | pages = 467–478 | date = February 2019 | pmid = 30483773 | doi = 10.3892/ijo.2018.4643 | pmc = 6317669 }}

{{cite journal | vauthors = Witkiewicz AK, McMillan EA, Balaji U, Baek G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, Choti MA, Yeo CJ, McCue P, White MA, Knudsen ES | display-authors = 6 | title = Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets | journal = Nature Communications | volume = 6 | pages = 6744 | date = April 2015 | pmid = 25855536 | doi = 10.1038/ncomms7744 | pmc = 4403382 | bibcode = 2015NatCo...6.6744W }}

{{cite journal | vauthors = Sutherland LC, Thibault P, Durand M, Lapointe E, Knee JM, Beauvais A, Kalatskaya I, Hunt SC, Loiselle JJ, Roy JG, Tessier SJ, Ybazeta G, Stein L, Kothary R, Klinck R, Chabot B | display-authors = 6 | title = Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA | journal = BMC Molecular Biology | volume = 18 | issue = 1 | pages = 19 | date = July 2017 | pmid = 28728573 | doi = 10.1186/s12867-017-0096-x | pmc = 5520337 | doi-access = free }}

{{cite journal | vauthors = Mohan N, Kumar V, Kandala DT, Kartha CC, Laishram RS | title = A Splicing-Independent Function of RBM10 Controls Specific 3' UTR Processing to Regulate Cardiac Hypertrophy | journal = Cell Reports | volume = 24 | issue = 13 | pages = 3539–3553 | date = September 2018 | pmid = 30257214 | doi = 10.1016/j.celrep.2018.08.077 | doi-access = free }}

{{cite journal | vauthors = Treiber T, Treiber N, Plessmann U, Harlander S, Daiß JL, Eichner N, Lehmann G, Schall K, Urlaub H, Meister G | display-authors = 6 | title = A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis | journal = Molecular Cell | volume = 66 | issue = 2 | pages = 270–284.e13 | date = April 2017 | pmid = 28431233 | doi = 10.1016/j.molcel.2017.03.014 | doi-access = free }}

{{cite journal | vauthors = Guan G, Li R, Tang W, Liu T, Su Z, Wang Y, Tan J, Jiang S, Wang K | s2cid = 206612545 | display-authors = 6 | title = Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells | journal = Tumour Biology | volume = 39 | issue = 3 | pages = 1010428317691740 | date = March 2017 | pmid = 28347232 | doi = 10.1177/1010428317691740 | doi-access = free }}

{{cite journal | vauthors = Kunimoto H, Inoue A, Kojima H, Yang J, Zhao H, Tsuruta D, Nakajima K | title = RBM10 regulates centriole duplication in HepG2 cells by ectopically assembling PLK4-STIL complexes in the nucleus | journal = Genes to Cells | volume = 25 | issue = 2 | pages = 100–110 | date = February 2020 | pmid = 31820547 | doi = 10.1111/gtc.12741 | s2cid = 209165475 | doi-access = free }}

{{cite journal | vauthors = Nagase T, Seki N, Tanaka A, Ishikawa K, Nomura N | title = Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1 | journal = DNA Research | volume = 2 | issue = 4 | pages = 167–74, 199–210 | date = August 1995 | pmid = 8590280 | doi = 10.1093/dnares/2.4.167 | doi-access = free }}

{{cite journal | vauthors = Salichs E, Ledda A, Mularoni L, Albà MM, de la Luna S | title = Genome-wide analysis of histidine repeats reveals their role in the localization of human proteins to the nuclear speckles compartment | journal = PLOS Genetics | volume = 5 | issue = 3 | pages = e1000397 | date = March 2009 | pmid = 19266028 | doi = 10.1371/journal.pgen.1000397 | pmc = 2644819 | doi-access = free }}

{{cite journal | vauthors = Coleman MP, Ambrose HJ, Carrel L, Németh AH, Willard HF, Davies KE | title = A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status | journal = Genomics | volume = 31 | issue = 1 | pages = 135–8 | date = January 1996 | pmid = 8808293 | doi = 10.1006/geno.1996.0022 }}

{{cite journal | vauthors = Thiselton DL, McDowall J, Brandau O, Ramser J, d'Esposito F, Bhattacharya SS, Ross MT, Hardcastle AJ, Meindl A | display-authors = 6 | title = An integrated, functionally annotated gene map of the DXS8026-ELK1 interval on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders | journal = Genomics | volume = 79 | issue = 4 | pages = 560–72 | date = April 2002 | pmid = 11944989 | doi = 10.1006/geno.2002.6733 }}

{{cite journal | vauthors = Goto Y, Kimura H | title = Inactive X chromosome-specific histone H3 modifications and CpG hypomethylation flank a chromatin boundary between an X-inactivated and an escape gene | journal = Nucleic Acids Research | volume = 37 | issue = 22 | pages = 7416–28 | date = December 2009 | pmid = 19843608 | doi = 10.1093/nar/gkp860 | pmc = 2794193 }}

{{cite journal | vauthors = Sun Y, Bao Y, Han W, Song F, Shen X, Zhao J, Zuo J, Saffen D, Chen W, Wang Z, You X, Wang Y | display-authors = 6 | title = Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay | journal = Nucleic Acids Research | volume = 45 | issue = 14 | pages = 8524–8540 | date = August 2017 | pmid = 28586478 | doi = 10.1093/nar/gkx508 | pmc = 5737846 }}

{{cite journal | vauthors = Stes E, Laga M, Walton A, Samyn N, Timmerman E, De Smet I, Goormachtig S, Gevaert K | display-authors = 6 | title = A COFRADIC protocol to study protein ubiquitination | journal = Journal of Proteome Research | volume = 13 | issue = 6 | pages = 3107–13 | date = June 2014 | pmid = 24816145 | doi = 10.1021/pr4012443 }}

{{cite journal | vauthors = Akimov V, Barrio-Hernandez I, Hansen SV, Hallenborg P, Pedersen AK, Bekker-Jensen DB, Puglia M, Christensen SD, Vanselow JT, Nielsen MM, Kratchmarova I, Kelstrup CD, Olsen JV, Blagoev B | display-authors = 6 | title = UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites | journal = Nature Structural & Molecular Biology | volume = 25 | issue = 7 | pages = 631–640 | date = July 2018 | pmid = 29967540 | doi = 10.1038/s41594-018-0084-y | s2cid = 49559977 }}

{{cite journal | vauthors = Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M | s2cid = 206520776 | display-authors = 6 | title = Lysine acetylation targets protein complexes and co-regulates major cellular functions | journal = Science | volume = 325 | issue = 5942 | pages = 834–40 | date = August 2009 | pmid = 19608861 | doi = 10.1126/science.1175371 | bibcode = 2009Sci...325..834C | doi-access = free }}

{{cite journal | vauthors = Guo A, Gu H, Zhou J, Mulhern D, Wang Y, Lee KA, Yang V, Aguiar M, Kornhauser J, Jia X, Ren J, Beausoleil SA, Silva JC, Vemulapalli V, Bedford MT, Comb MJ | display-authors = 6 | title = Immunoaffinity enrichment and mass spectrometry analysis of protein methylation | journal = Molecular & Cellular Proteomics | volume = 13 | issue = 1 | pages = 372–87 | date = January 2014 | pmid = 24129315 | doi = 10.1074/mcp.O113.027870 | pmc = 3879628 | doi-access = free }}

{{cite journal | vauthors = Johnston JJ, Teer JK, Cherukuri PF, Hansen NF, Loftus SK, Chong K, Mullikin JC, Biesecker LG | display-authors = 6 | title = Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate | journal = American Journal of Human Genetics | volume = 86 | issue = 5 | pages = 743–8 | date = May 2010 | pmid = 20451169 | doi = 10.1016/j.ajhg.2010.04.007 | pmc = 2868995 }}

{{cite journal | vauthors = Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, Lawrence MS, Stojanov P, Cibulskis K, Choi K, de Waal L, Sharifnia T, Brooks A, Greulich H, Banerji S, Zander T, Seidel D, Leenders F, Ansén S, Ludwig C, Engel-Riedel W, Stoelben E, Wolf J, Goparju C, Thompson K, Winckler W, Kwiatkowski D, Johnson BE, Jänne PA, Miller VA, Pao W, Travis WD, Pass HI, Gabriel SB, Lander ES, Thomas RK, Garraway LA, Getz G, Meyerson M | display-authors = 6 | title = Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing | journal = Cell | volume = 150 | issue = 6 | pages = 1107–20 | date = September 2012 | pmid = 22980975 | doi = 10.1016/j.cell.2012.08.029 | pmc = 3557932 }}

{{cite journal | vauthors = Seiler M, Peng S, Agrawal AA, Palacino J, Teng T, Zhu P, Smith PG, Buonamici S, Yu L | display-authors = 6 | title = Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types | journal = Cell Reports | volume = 23 | issue = 1 | pages = 282–296.e4 | date = April 2018 | pmid = 29617667 | doi = 10.1016/j.celrep.2018.01.088 | pmc = 5933844 }}

{{cite journal | title = Comprehensive molecular profiling of lung adenocarcinoma | journal = Nature | volume = 511 | issue = 7511 | pages = 543–50 | date = July 2014 | pmid = 25079552 | doi = 10.1038/nature13385 | author1 = Cancer Genome Atlas Research Network | pmc = 4231481 | bibcode = 2014Natur.511..543T }}

{{cite journal | vauthors = Yuan Y, Liu L, Chen H, Wang Y, Xu Y, Mao H, Li J, Mills GB, Shu Y, Li L, Liang H | display-authors = 6 | title = Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients | journal = Cancer Cell | volume = 29 | issue = 5 | pages = 711–722 | date = May 2016 | pmid = 27165743 | doi = 10.1016/j.ccell.2016.04.001 | pmc = 4864951 }}

{{cite journal | vauthors = Yin LL, Wen XM, Li M, Xu YM, Zhao XF, Li J, Wang XW | title = A gene mutation in RNA-binding protein 10 is associated with lung adenocarcinoma progression and poor prognosis | journal = Oncology Letters | volume = 16 | issue = 5 | pages = 6283–6292 | date = November 2018 | pmid = 30405763 | doi = 10.3892/ol.2018.9496 | pmc = 6202477 }}

{{cite journal |last1=Powis |first1=Z |last2=Hart |first2=A |last3=Cherny |first3=S |last4=Petrik |first4=I |last5=Palmaer |first5=E |last6=Tang |first6=S |last7=Jones |first7=C |title=Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration. |journal=BMC Medical Genetics |date=2 June 2017 |volume=18 |issue=1 |pages=60 |doi=10.1186/s12881-017-0426-3 |pmid=28577551|pmc=5455125 |doi-access=free }}

{{cite journal | vauthors = Gripp KW, Hopkins E, Johnston JJ, Krause C, Dobyns WB, Biesecker LG | title = Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene | journal = American Journal of Medical Genetics. Part A | volume = 155A | issue = 10 | pages = 2516–20 | date = October 2011 | pmid = 21910224 | doi = 10.1002/ajmg.a.34190 | pmc = 3183328 }}

{{cite journal | vauthors = Niceta M, Barresi S, Pantaleoni F, Capolino R, Dentici ML, Ciolfi A, Pizzi S, Bartuli A, Dallapiccola B, Tartaglia M, Digilio MC | display-authors = 6 | title = TARP syndrome: Long-term survival, anatomic patterns of congenital heart defects, differential diagnosis and pathogenetic considerations | journal = European Journal of Medical Genetics | volume = 62 | issue = 6 | pages = 103534 | date = June 2019 | pmid = 30189253 | doi = 10.1016/j.ejmg.2018.09.001 | doi-access = free }}

{{cite journal | vauthors = Højland AT, Lolas I, Okkels H, Lautrup CK, Diness BR, Petersen MB, Nielsen IK | title = First reported adult patient with TARP syndrome: A case report | journal = American Journal of Medical Genetics. Part A | volume = 176 | issue = 12 | pages = 2915–2918 | date = December 2018 | pmid = 30462380 | doi = 10.1002/ajmg.a.40638 | pmc = 6587983 }}

{{cite journal | vauthors = Loiselle JJ, Sutherland LC | title = RBM10: Harmful or helpful-many factors to consider | journal = Journal of Cellular Biochemistry | volume = 119 | issue = 5 | pages = 3809–3818 | date = May 2018 | pmid = 29274279 | doi = 10.1002/jcb.26644 | pmc = 5901003 }}

{{cite journal | vauthors = Xia QY, Wang XT, Zhan XM, Tan X, Chen H, Liu Y, Shi SS, Wang X, Wei X, Ye SB, Li R, Ma HH, Lu ZF, Zhou XJ, Rao Q | s2cid = 205918230 | display-authors = 6 | title = Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3 | journal = The American Journal of Surgical Pathology | volume = 41 | issue = 5 | pages = 663–676 | date = May 2017 | pmid = 28288037 | doi = 10.1097/PAS.0000000000000837 }}

{{cite journal | vauthors = Argani P, Zhang L, Reuter VE, Tickoo SK, Antonescu CR | title = RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH | journal = The American Journal of Surgical Pathology | volume = 41 | issue = 5 | pages = 655–662 | date = May 2017 | pmid = 28296677 | doi = 10.1097/PAS.0000000000000835 | pmc = 5391276 }}

{{cite journal | vauthors = Kato I, Furuya M, Baba M, Kameda Y, Yasuda M, Nishimoto K, Oyama M, Yamasaki T, Ogawa O, Niino H, Nakaigawa N, Yano Y, Sakamoto K, Urata Y, Mikami K, Yamasaki S, Tanaka R, Takagi T, Kondo T, Nagashima Y | display-authors = 6 | title = RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review | journal = Histopathology | volume = 75 | issue = 2 | pages = 254–265 | date = August 2019 | pmid = 30908700 | doi = 10.1111/his.13866 | s2cid = 85516169 }}

{{cite journal | vauthors = Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N, Shiratori K | display-authors = 6 | title = Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas | journal = Scientific Reports | year = 2011 | volume = 1 | pages = 161 | pmid = 22355676 | doi = 10.1038/srep00161 | pmc = 3240977 | bibcode = 2011NatSR...1E.161F }}

{{cite journal | vauthors = Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, Nosho K, Nowak JA, Lawrence MS, Giovannucci EL, Chan AT, Ng K, Meyerhardt JA, Van Allen EM, Getz G, Gabriel SB, Lander ES, Wu CJ, Fuchs CS, Ogino S, Garraway LA | display-authors = 6 | title = Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma | journal = Cell Reports | volume = 15 | issue = 4 | pages = 857–865 | date = April 2016 | pmid = 27149842 | doi = 10.1016/j.celrep.2016.03.075 | pmc = 4850357 }}

{{cite journal | vauthors = Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G | display-authors = 6 | title = Discovery and saturation analysis of cancer genes across 21 tumour types | journal = Nature | volume = 505 | issue = 7484 | pages = 495–501 | date = January 2014 | pmid = 24390350 | doi = 10.1038/nature12912 | pmc = 4048962 | bibcode = 2014Natur.505..495L }}

{{cite journal | vauthors = Ibrahimpasic T, Xu B, Landa I, Dogan S, Middha S, Seshan V, Deraje S, Carlson DL, Migliacci J, Knauf JA, Untch B, Berger MF, Morris L, Tuttle RM, Chan T, Fagin JA, Ghossein R, Ganly I | display-authors = 6 | title = RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence | journal = Clinical Cancer Research | volume = 23 | issue = 19 | pages = 5970–5980 | date = October 2017 | pmid = 28634282 | doi = 10.1158/1078-0432.CCR-17-1183 | pmc = 5626586 }}

{{cite journal | vauthors = Antonello ZA, Hsu N, Bhasin M, Roti G, Joshi M, Van Hummelen P, Ye E, Lo AS, Karumanchi SA, Bryke CR, Nucera C | display-authors = 6 | title = V600E | journal = Oncotarget | volume = 8 | issue = 49 | pages = 84743–84760 | date = October 2017 | pmid = 29156680 | doi = 10.18632/oncotarget.21262 | pmc = 5689570 }}

{{cite journal | vauthors = Ibrahimpasic T, Ghossein R, Shah JP, Ganly I | title = Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects | journal = Thyroid | volume = 29 | issue = 3 | pages = 311–321 | date = March 2019 | pmid = 30747050 | doi = 10.1089/thy.2018.0509 | pmc = 6437626 }}

{{cite journal | vauthors = Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S, Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe D, de Sauvage FJ, Faham M, Seshagiri S | display-authors = 6 | title = Diverse somatic mutation patterns and pathway alterations in human cancers | journal = Nature | volume = 466 | issue = 7308 | pages = 869–73 | date = August 2010 | pmid = 20668451 | doi = 10.1038/nature09208 | pmc = 3026267 | bibcode = 2010Natur.466..869K }}

{{cite journal | vauthors = Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, Meinhardt M, Hennig S, Kaplan AB, Fujio S, Kuter BM, Bertalan MS, Miller JJ, Batten JM, Ely HA, Christiansen J, Baretton GB, Stemmer-Rachamimov AO, Santagata S, Rivera MN, Barker FG, Schackert G, Wakimoto H, Iafrate AJ, Carter SL, Cahill DP, Brastianos PK | s2cid = 52039057 | display-authors = 6 | title = DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome | journal = Acta Neuropathologica | volume = 136 | issue = 5 | pages = 779–792 | date = November 2018 | pmid = 30123936 | doi = 10.1007/s00401-018-1899-7 }}

{{cite journal | vauthors = Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M | display-authors = 6 | title = RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report | journal = Cancer Genetics | volume = 231-232 | pages = 41–45 | date = February 2019 | pmid = 30803556 | doi = 10.1016/j.cancergen.2019.01.001 | s2cid = 73477150 }}

{{cite journal | vauthors = Misquitta-Ali CM, Cheng E, O'Hanlon D, Liu N, McGlade CJ, Tsao MS, Blencowe BJ | title = Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer | journal = Molecular and Cellular Biology | volume = 31 | issue = 1 | pages = 138–50 | date = January 2011 | pmid = 21041478 | doi = 10.1128/MCB.00709-10 | pmc = 3019846 }}

{{cite journal | vauthors = Cieply B, Carstens RP | title = Functional roles of alternative splicing factors in human disease | journal = Wiley Interdisciplinary Reviews. RNA | year = 2015 | volume = 6 | issue = 3 | pages = 311–26 | pmid = 25630614 | doi = 10.1002/wrna.1276 | pmc = 4671264 }}

{{cite journal | vauthors = Mourtada-Maarabouni M, Williams GT | title = RBM5/LUCA-15--tumour suppression by control of apoptosis and the cell cycle? | journal = TheScientificWorldJournal | volume = 2 | pages = 1885–90 | date = July 2002 | pmid = 12920317 | doi = 10.1100/tsw.2002.859 | pmc = 6009235 | doi-access = free }}

{{cite journal | vauthors = Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ | title = 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis | journal = Cancer Research | volume = 66 | issue = 7 | pages = 3419–27 | date = April 2006 | pmid = 16585163 | doi = 10.1158/0008-5472.CAN-05-1667 | doi-access = free }}

{{cite journal | vauthors = Fushimi K, Ray P, Kar A, Wang L, Sutherland LC, Wu JY | title = Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5 | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 105 | issue = 41 | pages = 15708–13 | date = October 2008 | pmid = 18840686 | doi = 10.1073/pnas.0805569105 | pmc = 2572934 | bibcode = 2008PNAS..10515708F | doi-access = free }}

{{cite journal | vauthors = Bonnal S, Martínez C, Förch P, Bachi A, Wilm M, Valcárcel J | title = RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition | journal = Molecular Cell | volume = 32 | issue = 1 | pages = 81–95 | date = October 2008 | pmid = 18851835 | doi = 10.1016/j.molcel.2008.08.008 | doi-access = free }}

{{cite journal | vauthors = Sutherland LC, Wang K, Robinson AG | title = RBM5 as a putative tumor suppressor gene for lung cancer | journal = Journal of Thoracic Oncology | volume = 5 | issue = 3 | pages = 294–8 | date = March 2010 | pmid = 20186023 | doi = 10.1097/JTO.0b013e3181c6e330 | doi-access = free }}

{{cite journal | vauthors = Jamsai D, Watkins DN, O'Connor AE, Merriner DJ, Gursoy S, Bird AD, Kumar B, Miller A, Cole TJ, Jenkins BJ, O'Bryan MK | display-authors = 6 | title = In vivo evidence that RBM5 is a tumour suppressor in the lung | journal = Scientific Reports | volume = 7 | issue = 1 | pages = 16323 | date = November 2017 | pmid = 29176597 | doi = 10.1038/s41598-017-15874-9 | pmc = 5701194 | bibcode = 2017NatSR...716323J }}

{{cite journal | vauthors = Wang Q, Wang F, Zhong W, Ling H, Wang J, Cui J, Xie T, Wen S, Chen J | display-authors = 6 | title = RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma | journal = Gene | volume = 697 | pages = 26–34 | date = May 2019 | pmid = 30772516 | doi = 10.1016/j.gene.2019.02.025 | s2cid = 73456531 }}

{{cite journal | vauthors = Coomer AO, Black F, Greystoke A, Munkley J, Elliott DJ | title = Alternative splicing in lung cancer | journal = Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms | year = 2019 | volume = 1862 | issue = 11–12 | pages = 194388 | pmid = 31152916 | doi = 10.1016/j.bbagrm.2019.05.006 | s2cid = 173188639 }}

{{cite journal | vauthors = Deckert J, Hartmuth K, Boehringer D, Behzadnia N, Will CL, Kastner B, Stark H, Urlaub H, Lührmann R | display-authors = 6 | title = Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions | journal = Molecular and Cellular Biology | volume = 26 | issue = 14 | pages = 5528–43 | date = July 2006 | pmid = 16809785 | doi = 10.1128/MCB.00582-06 | pmc = 1592722 }}

{{cite journal | vauthors = Papasaikas P, Tejedor JR, Vigevani L, Valcárcel J | s2cid = 11133534 | title = Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery | journal = Molecular Cell | volume = 57 | issue = 1 | pages = 7–22 | date = January 2015 | pmid = 25482510 | doi = 10.1016/j.molcel.2014.10.030 | doi-access = free | hdl = 10230/45908 | hdl-access = free }}

{{cite journal | vauthors = Ule J, Blencowe BJ | title = Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution | journal = Molecular Cell | volume = 76 | issue = 2 | pages = 329–345 | date = October 2019 | pmid = 31626751 | doi = 10.1016/j.molcel.2019.09.017 | doi-access = free }}

{{cite journal | vauthors = Collins KM, Kainov YA, Christodolou E, Ray D, Morris Q, Hughes T, Taylor IA, Makeyev EV, Ramos A | display-authors = 6 | title = An RRM-ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion | journal = Nucleic Acids Research | volume = 45 | issue = 11 | pages = 6761–6774 | date = June 2017 | pmid = 28379442 | doi = 10.1093/nar/gkx225 | pmc = 5499739 }}

{{cite journal | vauthors = Yang X, Coulombe-Huntington J, Kang S, Sheynkman GM, Hao T, Richardson A, Sun S, Yang F, Shen YA, Murray RR, Spirohn K, Begg BE, Duran-Frigola M, MacWilliams A, Pevzner SJ, Zhong Q, Trigg SA, Tam S, Ghamsari L, Sahni N, Yi S, Rodriguez MD, Balcha D, Tan G, Costanzo M, Andrews B, Boone C, Zhou XJ, Salehi-Ashtiani K, Charloteaux B, Chen AA, Calderwood MA, Aloy P, Roth FP, Hill DE, Iakoucheva LM, Xia Y, Vidal M | display-authors = 6 | title = Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing | journal = Cell | volume = 164 | issue = 4 | pages = 805–17 | date = February 2016 | pmid = 26871637 | doi = 10.1016/j.cell.2016.01.029 | pmc = 4882190 }}

{{cite journal | vauthors = Tian W, Hu W, Shi X, Liu P, Ma X, Zhao W, Qu L, Zhang S, Shi W, Liu A, Cao J | display-authors = 6 | title = Comprehensive genomic profile of cholangiocarcinomas in China | journal = Oncology Letters | volume = 19 | issue = 4 | pages = 3101–3110 | date = April 2020 | pmid = 32256810 | doi = 10.3892/ol.2020.11429 | pmc = 7074170 }}

{{cite journal | vauthors = Schwab ME, Song H, Mattis A, Phelps A, Vu LT, Huang FW, Nijagal A | title = De novo somatic mutations and KRAS amplification are associated with cholangiocarcinoma in a patient with a history of choledochal cyst | journal = Journal of Pediatric Surgery | date = March 2020 | volume = 55 | issue = 12 | pages = 2657–2661 | pmid = 32295706 | doi = 10.1016/j.jpedsurg.2020.03.008 | pmc = 7942710 | doi-access = free }}

{{cite journal | vauthors = Balachandran VP, Łuksza M, Zhao JN, Makarov V, Moral JA, Remark R, Herbst B, Askan G, Bhanot U, Senbabaoglu Y, Wells DK, Cary CI, Grbovic-Huezo O, Attiyeh M, Medina B, Zhang J, Loo J, Saglimbeni J, Abu-Akeel M, Zappasodi R, Riaz N, Smoragiewicz M, Kelley ZL, Basturk O, Gönen M, Levine AJ, Allen PJ, Fearon DT, Merad M, Gnjatic S, Iacobuzio-Donahue CA, Wolchok JD, DeMatteo RP, Chan TA, Greenbaum BD, Merghoub T, Leach SD | display-authors = 6 | title = Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer | journal = Nature | volume = 551 | issue = 7681 | pages = 512–516 | date = November 2017 | pmid = 29132146 | doi = 10.1038/nature24462 | pmc = 6145146 | bibcode = 2017Natur.551..512B }}

{{cite journal | vauthors = Siegel RL, Miller KD, Jemal A | title = Cancer statistics, 2018 | journal = CA: A Cancer Journal for Clinicians | volume = 68 | issue = 1 | pages = 7–30 | date = January 2018 | pmid = 29313949 | doi = 10.3322/caac.21442 | doi-access = free }}

{{cite journal | vauthors = Pozzi B, Bragado L, Mammi P, Torti MF, Gaioli N, Gebhard LG, García Solá ME, Vaz-Drago R, Iglesias NG, García CC, Gamarnik AV, Srebrow A | display-authors = 6 | title = Dengue virus targets RBM10 deregulating host cell splicing and innate immune response | journal = Nucleic Acids Research | volume = 48 | issue = 12 | pages = 6824–6838 | date = July 2020 | pmid = 32432721 | doi = 10.1093/nar/gkaa340 | pmc = 7337517 }}

{{cite journal | vauthors = Inoue A, Takahashi KP, Kimura M, Watanabe T, Morisawa S | title = Molecular cloning of a RNA binding protein, S1-1 | journal = Nucleic Acids Research | volume = 24 | issue = 15 | pages = 2990–7 | date = August 1996 | pmid = 8760884 | doi = 10.1093/nar/24.15.2990 | pmc = 146028 }}

{{cite journal | vauthors = Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabási AL, Vidal M, Zoghbi HY | s2cid = 13709685 | display-authors = 6 | title = A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration | journal = Cell | volume = 125 | issue = 4 | pages = 801–14 | date = May 2006 | pmid = 16713569 | doi = 10.1016/j.cell.2006.03.032 | doi-access = free }}

}}